nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylphenidate—CYP2D6—Hydroxyurea—psoriasis	0.0616	0.441	CbGbCtD
Methylphenidate—CYP2D6—Cholecalciferol—psoriasis	0.0373	0.267	CbGbCtD
Methylphenidate—CYP2D6—Cyclosporine—psoriasis	0.0245	0.176	CbGbCtD
Methylphenidate—CYP2D6—Dexamethasone—psoriasis	0.0162	0.116	CbGbCtD
Methylphenidate—Discomfort—Betamethasone—psoriasis	0.00018	0.000209	CcSEcCtD
Methylphenidate—Discomfort—Dexamethasone—psoriasis	0.00018	0.000209	CcSEcCtD
Methylphenidate—Dyspepsia—Hydrocortisone—psoriasis	0.00018	0.000209	CcSEcCtD
Methylphenidate—Haemoglobin—Methotrexate—psoriasis	0.00018	0.000209	CcSEcCtD
Methylphenidate—Rash—Mycophenolic acid—psoriasis	0.000179	0.000209	CcSEcCtD
Methylphenidate—Dermatitis—Mycophenolic acid—psoriasis	0.000179	0.000208	CcSEcCtD
Methylphenidate—Pain—Prednisolone—psoriasis	0.000179	0.000208	CcSEcCtD
Methylphenidate—Haemorrhage—Methotrexate—psoriasis	0.000179	0.000208	CcSEcCtD
Methylphenidate—Urticaria—Mycophenolate mofetil—psoriasis	0.000178	0.000207	CcSEcCtD
Methylphenidate—Headache—Mycophenolic acid—psoriasis	0.000178	0.000207	CcSEcCtD
Methylphenidate—Decreased appetite—Hydrocortisone—psoriasis	0.000178	0.000207	CcSEcCtD
Methylphenidate—Pharyngitis—Methotrexate—psoriasis	0.000178	0.000207	CcSEcCtD
Methylphenidate—Abdominal pain—Mycophenolate mofetil—psoriasis	0.000178	0.000206	CcSEcCtD
Methylphenidate—Body temperature increased—Mycophenolate mofetil—psoriasis	0.000178	0.000206	CcSEcCtD
Methylphenidate—Urinary tract disorder—Methotrexate—psoriasis	0.000177	0.000206	CcSEcCtD
Methylphenidate—Gastrointestinal disorder—Hydrocortisone—psoriasis	0.000177	0.000205	CcSEcCtD
Methylphenidate—Fatigue—Hydrocortisone—psoriasis	0.000176	0.000205	CcSEcCtD
Methylphenidate—Vision blurred—Prednisone—psoriasis	0.000176	0.000204	CcSEcCtD
Methylphenidate—Urethral disorder—Methotrexate—psoriasis	0.000176	0.000204	CcSEcCtD
Methylphenidate—Musculoskeletal discomfort—Triamcinolone—psoriasis	0.000176	0.000204	CcSEcCtD
Methylphenidate—Pain—Hydrocortisone—psoriasis	0.000175	0.000203	CcSEcCtD
Methylphenidate—Anaphylactic shock—Dexamethasone—psoriasis	0.000175	0.000203	CcSEcCtD
Methylphenidate—Oedema—Betamethasone—psoriasis	0.000175	0.000203	CcSEcCtD
Methylphenidate—Oedema—Dexamethasone—psoriasis	0.000175	0.000203	CcSEcCtD
Methylphenidate—Anaphylactic shock—Betamethasone—psoriasis	0.000175	0.000203	CcSEcCtD
Methylphenidate—Insomnia—Triamcinolone—psoriasis	0.000174	0.000203	CcSEcCtD
Methylphenidate—Infection—Betamethasone—psoriasis	0.000174	0.000202	CcSEcCtD
Methylphenidate—Infection—Dexamethasone—psoriasis	0.000174	0.000202	CcSEcCtD
Methylphenidate—Ill-defined disorder—Prednisone—psoriasis	0.000173	0.000201	CcSEcCtD
Methylphenidate—Paraesthesia—Triamcinolone—psoriasis	0.000173	0.000201	CcSEcCtD
Methylphenidate—Feeling abnormal—Prednisolone—psoriasis	0.000173	0.000201	CcSEcCtD
Methylphenidate—Visual impairment—Methotrexate—psoriasis	0.000173	0.000201	CcSEcCtD
Methylphenidate—Anaemia—Prednisone—psoriasis	0.000172	0.0002	CcSEcCtD
Methylphenidate—Shock—Dexamethasone—psoriasis	0.000172	0.0002	CcSEcCtD
Methylphenidate—Shock—Betamethasone—psoriasis	0.000172	0.0002	CcSEcCtD
Methylphenidate—Dyspnoea—Triamcinolone—psoriasis	0.000172	0.0002	CcSEcCtD
Methylphenidate—Nervous system disorder—Dexamethasone—psoriasis	0.000171	0.000199	CcSEcCtD
Methylphenidate—Nervous system disorder—Betamethasone—psoriasis	0.000171	0.000199	CcSEcCtD
Methylphenidate—Agitation—Prednisone—psoriasis	0.000171	0.000199	CcSEcCtD
Methylphenidate—Thrombocytopenia—Dexamethasone—psoriasis	0.000171	0.000199	CcSEcCtD
Methylphenidate—Thrombocytopenia—Betamethasone—psoriasis	0.000171	0.000199	CcSEcCtD
Methylphenidate—Tachycardia—Betamethasone—psoriasis	0.000171	0.000198	CcSEcCtD
Methylphenidate—Tachycardia—Dexamethasone—psoriasis	0.000171	0.000198	CcSEcCtD
Methylphenidate—Angioedema—Prednisone—psoriasis	0.00017	0.000198	CcSEcCtD
Methylphenidate—Hypersensitivity—Cyclosporine—psoriasis	0.00017	0.000197	CcSEcCtD
Methylphenidate—Dyspepsia—Triamcinolone—psoriasis	0.00017	0.000197	CcSEcCtD
Methylphenidate—Erythema multiforme—Methotrexate—psoriasis	0.000169	0.000197	CcSEcCtD
Methylphenidate—Nausea—Mycophenolic acid—psoriasis	0.000169	0.000197	CcSEcCtD
Methylphenidate—Hyperhidrosis—Betamethasone—psoriasis	0.000169	0.000196	CcSEcCtD
Methylphenidate—Hyperhidrosis—Dexamethasone—psoriasis	0.000169	0.000196	CcSEcCtD
Methylphenidate—Feeling abnormal—Hydrocortisone—psoriasis	0.000169	0.000196	CcSEcCtD
Methylphenidate—Malaise—Prednisone—psoriasis	0.000168	0.000196	CcSEcCtD
Methylphenidate—Vertigo—Prednisone—psoriasis	0.000168	0.000195	CcSEcCtD
Methylphenidate—Eye disorder—Methotrexate—psoriasis	0.000167	0.000195	CcSEcCtD
Methylphenidate—Gastrointestinal pain—Hydrocortisone—psoriasis	0.000167	0.000195	CcSEcCtD
Methylphenidate—Syncope—Prednisone—psoriasis	0.000167	0.000194	CcSEcCtD
Methylphenidate—Anorexia—Betamethasone—psoriasis	0.000167	0.000194	CcSEcCtD
Methylphenidate—Anorexia—Dexamethasone—psoriasis	0.000167	0.000194	CcSEcCtD
Methylphenidate—Urticaria—Prednisolone—psoriasis	0.000166	0.000193	CcSEcCtD
Methylphenidate—Cardiac disorder—Methotrexate—psoriasis	0.000166	0.000193	CcSEcCtD
Methylphenidate—Fatigue—Triamcinolone—psoriasis	0.000166	0.000193	CcSEcCtD
Methylphenidate—Hypersensitivity—Mycophenolate mofetil—psoriasis	0.000166	0.000192	CcSEcCtD
Methylphenidate—Asthenia—Cyclosporine—psoriasis	0.000165	0.000192	CcSEcCtD
Methylphenidate—Pain—Triamcinolone—psoriasis	0.000165	0.000192	CcSEcCtD
Methylphenidate—Loss of consciousness—Prednisone—psoriasis	0.000164	0.000191	CcSEcCtD
Methylphenidate—Pruritus—Cyclosporine—psoriasis	0.000163	0.000189	CcSEcCtD
Methylphenidate—Urticaria—Hydrocortisone—psoriasis	0.000163	0.000189	CcSEcCtD
Methylphenidate—Angiopathy—Methotrexate—psoriasis	0.000163	0.000189	CcSEcCtD
Methylphenidate—Immune system disorder—Methotrexate—psoriasis	0.000162	0.000188	CcSEcCtD
Methylphenidate—Abdominal pain—Hydrocortisone—psoriasis	0.000162	0.000188	CcSEcCtD
Methylphenidate—Body temperature increased—Hydrocortisone—psoriasis	0.000162	0.000188	CcSEcCtD
Methylphenidate—Convulsion—Prednisone—psoriasis	0.000162	0.000188	CcSEcCtD
Methylphenidate—Mediastinal disorder—Methotrexate—psoriasis	0.000161	0.000188	CcSEcCtD
Methylphenidate—Asthenia—Mycophenolate mofetil—psoriasis	0.000161	0.000187	CcSEcCtD
Methylphenidate—Hypertension—Prednisone—psoriasis	0.000161	0.000187	CcSEcCtD
Methylphenidate—Chills—Methotrexate—psoriasis	0.000161	0.000187	CcSEcCtD
Methylphenidate—Musculoskeletal discomfort—Dexamethasone—psoriasis	0.000159	0.000185	CcSEcCtD
Methylphenidate—Musculoskeletal discomfort—Betamethasone—psoriasis	0.000159	0.000185	CcSEcCtD
Methylphenidate—Pruritus—Mycophenolate mofetil—psoriasis	0.000159	0.000185	CcSEcCtD
Methylphenidate—Arthralgia—Prednisone—psoriasis	0.000159	0.000185	CcSEcCtD
Methylphenidate—Myalgia—Prednisone—psoriasis	0.000159	0.000185	CcSEcCtD
Methylphenidate—Feeling abnormal—Triamcinolone—psoriasis	0.000159	0.000185	CcSEcCtD
Methylphenidate—Anxiety—Prednisone—psoriasis	0.000158	0.000184	CcSEcCtD
Methylphenidate—Alopecia—Methotrexate—psoriasis	0.000158	0.000184	CcSEcCtD
Methylphenidate—Insomnia—Dexamethasone—psoriasis	0.000158	0.000184	CcSEcCtD
Methylphenidate—Insomnia—Betamethasone—psoriasis	0.000158	0.000184	CcSEcCtD
Methylphenidate—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	0.000158	0.000183	CcSEcCtD
Methylphenidate—Diarrhoea—Cyclosporine—psoriasis	0.000158	0.000183	CcSEcCtD
Methylphenidate—Paraesthesia—Betamethasone—psoriasis	0.000157	0.000182	CcSEcCtD
Methylphenidate—Paraesthesia—Dexamethasone—psoriasis	0.000157	0.000182	CcSEcCtD
Methylphenidate—Discomfort—Prednisone—psoriasis	0.000157	0.000182	CcSEcCtD
Methylphenidate—Mental disorder—Methotrexate—psoriasis	0.000157	0.000182	CcSEcCtD
Methylphenidate—Erythema—Methotrexate—psoriasis	0.000156	0.000181	CcSEcCtD
Methylphenidate—Malnutrition—Methotrexate—psoriasis	0.000156	0.000181	CcSEcCtD
Methylphenidate—Hypersensitivity—Prednisolone—psoriasis	0.000154	0.000179	CcSEcCtD
Methylphenidate—Dyspepsia—Betamethasone—psoriasis	0.000154	0.000179	CcSEcCtD
Methylphenidate—Dyspepsia—Dexamethasone—psoriasis	0.000154	0.000179	CcSEcCtD
Methylphenidate—Diarrhoea—Mycophenolate mofetil—psoriasis	0.000154	0.000179	CcSEcCtD
Methylphenidate—Urticaria—Triamcinolone—psoriasis	0.000153	0.000178	CcSEcCtD
Methylphenidate—Body temperature increased—Triamcinolone—psoriasis	0.000152	0.000177	CcSEcCtD
Methylphenidate—Dizziness—Cyclosporine—psoriasis	0.000152	0.000177	CcSEcCtD
Methylphenidate—Anaphylactic shock—Prednisone—psoriasis	0.000152	0.000177	CcSEcCtD
Methylphenidate—Oedema—Prednisone—psoriasis	0.000152	0.000177	CcSEcCtD
Methylphenidate—Decreased appetite—Betamethasone—psoriasis	0.000152	0.000177	CcSEcCtD
Methylphenidate—Decreased appetite—Dexamethasone—psoriasis	0.000152	0.000177	CcSEcCtD
Methylphenidate—Infection—Prednisone—psoriasis	0.000151	0.000176	CcSEcCtD
Methylphenidate—Gastrointestinal disorder—Betamethasone—psoriasis	0.000151	0.000175	CcSEcCtD
Methylphenidate—Gastrointestinal disorder—Dexamethasone—psoriasis	0.000151	0.000175	CcSEcCtD
Methylphenidate—Back pain—Methotrexate—psoriasis	0.000151	0.000175	CcSEcCtD
Methylphenidate—Hypersensitivity—Hydrocortisone—psoriasis	0.000151	0.000175	CcSEcCtD
Methylphenidate—Fatigue—Betamethasone—psoriasis	0.000151	0.000175	CcSEcCtD
Methylphenidate—Fatigue—Dexamethasone—psoriasis	0.000151	0.000175	CcSEcCtD
Methylphenidate—Shock—Prednisone—psoriasis	0.00015	0.000174	CcSEcCtD
Methylphenidate—Pain—Betamethasone—psoriasis	0.00015	0.000174	CcSEcCtD
Methylphenidate—Pain—Dexamethasone—psoriasis	0.00015	0.000174	CcSEcCtD
Methylphenidate—Nervous system disorder—Prednisone—psoriasis	0.000149	0.000174	CcSEcCtD
Methylphenidate—Tachycardia—Prednisone—psoriasis	0.000149	0.000173	CcSEcCtD
Methylphenidate—Dizziness—Mycophenolate mofetil—psoriasis	0.000149	0.000173	CcSEcCtD
Methylphenidate—Skin disorder—Prednisone—psoriasis	0.000148	0.000172	CcSEcCtD
Methylphenidate—Hyperhidrosis—Prednisone—psoriasis	0.000147	0.000171	CcSEcCtD
Methylphenidate—Vision blurred—Methotrexate—psoriasis	0.000147	0.000171	CcSEcCtD
Methylphenidate—Asthenia—Hydrocortisone—psoriasis	0.000147	0.000171	CcSEcCtD
Methylphenidate—Vomiting—Cyclosporine—psoriasis	0.000146	0.00017	CcSEcCtD
Methylphenidate—Rash—Cyclosporine—psoriasis	0.000145	0.000169	CcSEcCtD
Methylphenidate—Anorexia—Prednisone—psoriasis	0.000145	0.000169	CcSEcCtD
Methylphenidate—Dermatitis—Cyclosporine—psoriasis	0.000145	0.000169	CcSEcCtD
Methylphenidate—Pruritus—Hydrocortisone—psoriasis	0.000145	0.000168	CcSEcCtD
Methylphenidate—Ill-defined disorder—Methotrexate—psoriasis	0.000145	0.000168	CcSEcCtD
Methylphenidate—Headache—Cyclosporine—psoriasis	0.000144	0.000168	CcSEcCtD
Methylphenidate—Anaemia—Methotrexate—psoriasis	0.000144	0.000168	CcSEcCtD
Methylphenidate—Feeling abnormal—Betamethasone—psoriasis	0.000144	0.000167	CcSEcCtD
Methylphenidate—Feeling abnormal—Dexamethasone—psoriasis	0.000144	0.000167	CcSEcCtD
Methylphenidate—Gastrointestinal pain—Dexamethasone—psoriasis	0.000143	0.000166	CcSEcCtD
Methylphenidate—Gastrointestinal pain—Betamethasone—psoriasis	0.000143	0.000166	CcSEcCtD
Methylphenidate—Vomiting—Mycophenolate mofetil—psoriasis	0.000143	0.000166	CcSEcCtD
Methylphenidate—Hypersensitivity—Triamcinolone—psoriasis	0.000142	0.000165	CcSEcCtD
Methylphenidate—Rash—Mycophenolate mofetil—psoriasis	0.000142	0.000165	CcSEcCtD
Methylphenidate—Dermatitis—Mycophenolate mofetil—psoriasis	0.000142	0.000164	CcSEcCtD
Methylphenidate—Headache—Mycophenolate mofetil—psoriasis	0.000141	0.000164	CcSEcCtD
Methylphenidate—Malaise—Methotrexate—psoriasis	0.000141	0.000163	CcSEcCtD
Methylphenidate—Vertigo—Methotrexate—psoriasis	0.00014	0.000163	CcSEcCtD
Methylphenidate—Diarrhoea—Hydrocortisone—psoriasis	0.00014	0.000163	CcSEcCtD
Methylphenidate—Leukopenia—Methotrexate—psoriasis	0.00014	0.000162	CcSEcCtD
Methylphenidate—Urticaria—Betamethasone—psoriasis	0.000139	0.000161	CcSEcCtD
Methylphenidate—Urticaria—Dexamethasone—psoriasis	0.000139	0.000161	CcSEcCtD
Methylphenidate—Musculoskeletal discomfort—Prednisone—psoriasis	0.000139	0.000161	CcSEcCtD
Methylphenidate—Dizziness—Prednisolone—psoriasis	0.000139	0.000161	CcSEcCtD
Methylphenidate—Asthenia—Triamcinolone—psoriasis	0.000138	0.000161	CcSEcCtD
Methylphenidate—Abdominal pain—Dexamethasone—psoriasis	0.000138	0.000161	CcSEcCtD
Methylphenidate—Body temperature increased—Betamethasone—psoriasis	0.000138	0.000161	CcSEcCtD
Methylphenidate—Body temperature increased—Dexamethasone—psoriasis	0.000138	0.000161	CcSEcCtD
Methylphenidate—Abdominal pain—Betamethasone—psoriasis	0.000138	0.000161	CcSEcCtD
Methylphenidate—Insomnia—Prednisone—psoriasis	0.000138	0.00016	CcSEcCtD
Methylphenidate—Nausea—Cyclosporine—psoriasis	0.000137	0.000159	CcSEcCtD
Methylphenidate—Paraesthesia—Prednisone—psoriasis	0.000137	0.000159	CcSEcCtD
Methylphenidate—Pruritus—Triamcinolone—psoriasis	0.000136	0.000158	CcSEcCtD
Methylphenidate—Cough—Methotrexate—psoriasis	0.000136	0.000158	CcSEcCtD
Methylphenidate—Dizziness—Hydrocortisone—psoriasis	0.000135	0.000157	CcSEcCtD
Methylphenidate—Convulsion—Methotrexate—psoriasis	0.000135	0.000157	CcSEcCtD
Methylphenidate—Dyspepsia—Prednisone—psoriasis	0.000134	0.000156	CcSEcCtD
Methylphenidate—Nausea—Mycophenolate mofetil—psoriasis	0.000133	0.000155	CcSEcCtD
Methylphenidate—Chest pain—Methotrexate—psoriasis	0.000133	0.000154	CcSEcCtD
Methylphenidate—Arthralgia—Methotrexate—psoriasis	0.000133	0.000154	CcSEcCtD
Methylphenidate—Myalgia—Methotrexate—psoriasis	0.000133	0.000154	CcSEcCtD
Methylphenidate—Decreased appetite—Prednisone—psoriasis	0.000132	0.000154	CcSEcCtD
Methylphenidate—Rash—Prednisolone—psoriasis	0.000132	0.000154	CcSEcCtD
Methylphenidate—Dermatitis—Prednisolone—psoriasis	0.000132	0.000153	CcSEcCtD
Methylphenidate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	0.000132	0.000153	CcSEcCtD
Methylphenidate—Fatigue—Prednisone—psoriasis	0.000131	0.000153	CcSEcCtD
Methylphenidate—Headache—Prednisolone—psoriasis	0.000131	0.000153	CcSEcCtD
Methylphenidate—Discomfort—Methotrexate—psoriasis	0.000131	0.000152	CcSEcCtD
Methylphenidate—Constipation—Prednisone—psoriasis	0.00013	0.000151	CcSEcCtD
Methylphenidate—Vomiting—Hydrocortisone—psoriasis	0.00013	0.000151	CcSEcCtD
Methylphenidate—Rash—Hydrocortisone—psoriasis	0.000129	0.00015	CcSEcCtD
Methylphenidate—Dermatitis—Hydrocortisone—psoriasis	0.000129	0.00015	CcSEcCtD
Methylphenidate—Confusional state—Methotrexate—psoriasis	0.000128	0.000149	CcSEcCtD
Methylphenidate—Headache—Hydrocortisone—psoriasis	0.000128	0.000149	CcSEcCtD
Methylphenidate—Dizziness—Triamcinolone—psoriasis	0.000127	0.000148	CcSEcCtD
Methylphenidate—Anaphylactic shock—Methotrexate—psoriasis	0.000127	0.000148	CcSEcCtD
Methylphenidate—Infection—Methotrexate—psoriasis	0.000126	0.000147	CcSEcCtD
Methylphenidate—Feeling abnormal—Prednisone—psoriasis	0.000125	0.000146	CcSEcCtD
Methylphenidate—Asthenia—Dexamethasone—psoriasis	0.000125	0.000146	CcSEcCtD
Methylphenidate—Asthenia—Betamethasone—psoriasis	0.000125	0.000146	CcSEcCtD
Methylphenidate—Nervous system disorder—Methotrexate—psoriasis	0.000125	0.000145	CcSEcCtD
Methylphenidate—Thrombocytopenia—Methotrexate—psoriasis	0.000125	0.000145	CcSEcCtD
Methylphenidate—Gastrointestinal pain—Prednisone—psoriasis	0.000125	0.000145	CcSEcCtD
Methylphenidate—Nausea—Prednisolone—psoriasis	0.000124	0.000145	CcSEcCtD
Methylphenidate—Pruritus—Dexamethasone—psoriasis	0.000124	0.000144	CcSEcCtD
Methylphenidate—Pruritus—Betamethasone—psoriasis	0.000124	0.000144	CcSEcCtD
Methylphenidate—Skin disorder—Methotrexate—psoriasis	0.000124	0.000144	CcSEcCtD
Methylphenidate—Hyperhidrosis—Methotrexate—psoriasis	0.000123	0.000143	CcSEcCtD
Methylphenidate—Vomiting—Triamcinolone—psoriasis	0.000123	0.000142	CcSEcCtD
Methylphenidate—Nausea—Hydrocortisone—psoriasis	0.000122	0.000141	CcSEcCtD
Methylphenidate—Rash—Triamcinolone—psoriasis	0.000121	0.000141	CcSEcCtD
Methylphenidate—Dermatitis—Triamcinolone—psoriasis	0.000121	0.000141	CcSEcCtD
Methylphenidate—Anorexia—Methotrexate—psoriasis	0.000121	0.000141	CcSEcCtD
Methylphenidate—Urticaria—Prednisone—psoriasis	0.000121	0.000141	CcSEcCtD
Methylphenidate—Headache—Triamcinolone—psoriasis	0.000121	0.00014	CcSEcCtD
Methylphenidate—Body temperature increased—Prednisone—psoriasis	0.00012	0.00014	CcSEcCtD
Methylphenidate—Abdominal pain—Prednisone—psoriasis	0.00012	0.00014	CcSEcCtD
Methylphenidate—Diarrhoea—Dexamethasone—psoriasis	0.00012	0.000139	CcSEcCtD
Methylphenidate—Diarrhoea—Betamethasone—psoriasis	0.00012	0.000139	CcSEcCtD
Methylphenidate—Musculoskeletal discomfort—Methotrexate—psoriasis	0.000116	0.000135	CcSEcCtD
Methylphenidate—Dizziness—Betamethasone—psoriasis	0.000116	0.000134	CcSEcCtD
Methylphenidate—Dizziness—Dexamethasone—psoriasis	0.000116	0.000134	CcSEcCtD
Methylphenidate—Insomnia—Methotrexate—psoriasis	0.000115	0.000134	CcSEcCtD
Methylphenidate—Nausea—Triamcinolone—psoriasis	0.000114	0.000133	CcSEcCtD
Methylphenidate—Paraesthesia—Methotrexate—psoriasis	0.000114	0.000133	CcSEcCtD
Methylphenidate—Dyspnoea—Methotrexate—psoriasis	0.000113	0.000132	CcSEcCtD
Methylphenidate—Somnolence—Methotrexate—psoriasis	0.000113	0.000131	CcSEcCtD
Methylphenidate—Hypersensitivity—Prednisone—psoriasis	0.000112	0.00013	CcSEcCtD
Methylphenidate—Dyspepsia—Methotrexate—psoriasis	0.000112	0.00013	CcSEcCtD
Methylphenidate—Vomiting—Betamethasone—psoriasis	0.000111	0.000129	CcSEcCtD
Methylphenidate—Vomiting—Dexamethasone—psoriasis	0.000111	0.000129	CcSEcCtD
Methylphenidate—Decreased appetite—Methotrexate—psoriasis	0.000111	0.000129	CcSEcCtD
Methylphenidate—Rash—Dexamethasone—psoriasis	0.00011	0.000128	CcSEcCtD
Methylphenidate—Rash—Betamethasone—psoriasis	0.00011	0.000128	CcSEcCtD
Methylphenidate—Dermatitis—Betamethasone—psoriasis	0.00011	0.000128	CcSEcCtD
Methylphenidate—Dermatitis—Dexamethasone—psoriasis	0.00011	0.000128	CcSEcCtD
Methylphenidate—Gastrointestinal disorder—Methotrexate—psoriasis	0.00011	0.000128	CcSEcCtD
Methylphenidate—Fatigue—Methotrexate—psoriasis	0.00011	0.000128	CcSEcCtD
Methylphenidate—Headache—Betamethasone—psoriasis	0.00011	0.000127	CcSEcCtD
Methylphenidate—Headache—Dexamethasone—psoriasis	0.00011	0.000127	CcSEcCtD
Methylphenidate—Asthenia—Prednisone—psoriasis	0.000109	0.000127	CcSEcCtD
Methylphenidate—Pain—Methotrexate—psoriasis	0.000109	0.000126	CcSEcCtD
Methylphenidate—Pruritus—Prednisone—psoriasis	0.000108	0.000125	CcSEcCtD
Methylphenidate—Feeling abnormal—Methotrexate—psoriasis	0.000105	0.000122	CcSEcCtD
Methylphenidate—Diarrhoea—Prednisone—psoriasis	0.000104	0.000121	CcSEcCtD
Methylphenidate—Gastrointestinal pain—Methotrexate—psoriasis	0.000104	0.000121	CcSEcCtD
Methylphenidate—Nausea—Dexamethasone—psoriasis	0.000104	0.000121	CcSEcCtD
Methylphenidate—Nausea—Betamethasone—psoriasis	0.000104	0.000121	CcSEcCtD
Methylphenidate—Urticaria—Methotrexate—psoriasis	0.000101	0.000118	CcSEcCtD
Methylphenidate—Dizziness—Prednisone—psoriasis	0.000101	0.000117	CcSEcCtD
Methylphenidate—Abdominal pain—Methotrexate—psoriasis	0.000101	0.000117	CcSEcCtD
Methylphenidate—Body temperature increased—Methotrexate—psoriasis	0.000101	0.000117	CcSEcCtD
Methylphenidate—Vomiting—Prednisone—psoriasis	9.68e-05	0.000113	CcSEcCtD
Methylphenidate—Rash—Prednisone—psoriasis	9.6e-05	0.000112	CcSEcCtD
Methylphenidate—Dermatitis—Prednisone—psoriasis	9.59e-05	0.000111	CcSEcCtD
Methylphenidate—Headache—Prednisone—psoriasis	9.54e-05	0.000111	CcSEcCtD
Methylphenidate—Hypersensitivity—Methotrexate—psoriasis	9.38e-05	0.000109	CcSEcCtD
Methylphenidate—Asthenia—Methotrexate—psoriasis	9.13e-05	0.000106	CcSEcCtD
Methylphenidate—Nausea—Prednisone—psoriasis	9.04e-05	0.000105	CcSEcCtD
Methylphenidate—Pruritus—Methotrexate—psoriasis	9e-05	0.000105	CcSEcCtD
Methylphenidate—Diarrhoea—Methotrexate—psoriasis	8.71e-05	0.000101	CcSEcCtD
Methylphenidate—Dizziness—Methotrexate—psoriasis	8.42e-05	9.78e-05	CcSEcCtD
Methylphenidate—Vomiting—Methotrexate—psoriasis	8.09e-05	9.4e-05	CcSEcCtD
Methylphenidate—Rash—Methotrexate—psoriasis	8.02e-05	9.33e-05	CcSEcCtD
Methylphenidate—Dermatitis—Methotrexate—psoriasis	8.02e-05	9.32e-05	CcSEcCtD
Methylphenidate—Headache—Methotrexate—psoriasis	7.97e-05	9.27e-05	CcSEcCtD
Methylphenidate—Nausea—Methotrexate—psoriasis	7.56e-05	8.79e-05	CcSEcCtD
